Literature DB >> 26732691

Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness.

H S Bond1, S G Sullivan2, B J Cowling1.   

Abstract

Influenza vaccination is the most practical means available for preventing influenza virus infection and is widely used in many countries. Because vaccine components and circulating strains frequently change, it is important to continually monitor vaccine effectiveness (VE). The test-negative design is frequently used to estimate VE. In this design, patients meeting the same clinical case definition are recruited and tested for influenza; those who test positive are the cases and those who test negative form the comparison group. When determining VE in these studies, the typical approach has been to use logistic regression, adjusting for potential confounders. Because vaccine coverage and influenza incidence change throughout the season, time is included among these confounders. While most studies use unconditional logistic regression, adjusting for time, an alternative approach is to use conditional logistic regression, matching on time. Here, we used simulation data to examine the potential for both regression approaches to permit accurate and robust estimates of VE. In situations where vaccine coverage changed during the influenza season, the conditional model and unconditional models adjusting for categorical week and using a spline function for week provided more accurate estimates. We illustrated the two approaches on data from a test-negative study of influenza VE against hospitalization in children in Hong Kong which resulted in the conditional logistic regression model providing the best fit to the data.

Entities:  

Keywords:  Epidemiology; influenza; influenza vaccines; statistics

Mesh:

Substances:

Year:  2016        PMID: 26732691      PMCID: PMC5545127          DOI: 10.1017/S095026881500309X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  28 in total

1.  Evidence of bias in estimates of influenza vaccine effectiveness in seniors.

Authors:  Lisa A Jackson; Michael L Jackson; Jennifer C Nelson; Kathleen M Neuzil; Noel S Weiss
Journal:  Int J Epidemiol       Date:  2005-12-20       Impact factor: 7.196

2.  Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2005-09-15

3.  Matched designs and causal diagrams.

Authors:  Mohammad A Mansournia; Miguel A Hernán; Sander Greenland
Journal:  Int J Epidemiol       Date:  2013-06       Impact factor: 7.196

4.  Variable definitions of the influenza season and their impact on vaccine effectiveness estimates.

Authors:  Sheena G Sullivan; Ee Laine Tay; Heath Kelly
Journal:  Vaccine       Date:  2013-07-09       Impact factor: 3.641

Review 5.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Authors:  Michael T Osterholm; Nicholas S Kelley; Alfred Sommer; Edward A Belongia
Journal:  Lancet Infect Dis       Date:  2011-10-25       Impact factor: 25.071

6.  Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia.

Authors:  Kylie S Carville; Kristina A Grant; Sheena G Sullivan; James E Fielding; Courtney R Lane; Lucinda Franklin; Julian Druce; Heath A Kelly
Journal:  Vaccine       Date:  2014-11-22       Impact factor: 3.641

7.  The test-negative design for estimating influenza vaccine effectiveness.

Authors:  Michael L Jackson; Jennifer C Nelson
Journal:  Vaccine       Date:  2013-03-13       Impact factor: 3.641

8.  Sparse-data bias accompanying overly fine stratification in an analysis of beryllium exposure and lung cancer risk.

Authors:  Kenneth J Rothman; Paul L Mosquin
Journal:  Ann Epidemiol       Date:  2012-12-06       Impact factor: 3.797

9.  I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe.

Authors:  Esther Kissling; Marta Valenciano; Jean Marie Cohen; Beatrix Oroszi; Anne-Sophie Barret; Caterina Rizzo; Pawel Stefanoff; Baltazar Nunes; Daniela Pitigoi; Amparo Larrauri; Isabelle Daviaud; Judit Krisztina Horvath; Joan O'Donnell; Thomas Seyler; Iwona Anna Paradowska-Stankiewicz; Pedro Pechirra; Alina Elena Ivanciuc; Silvia Jiménez-Jorge; Camelia Savulescu; Bruno Christian Ciancio; Alain Moren
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

10.  Differences in influenza seasonality by latitude, northern India.

Authors:  Parvaiz A Koul; Shobha Broor; Siddhartha Saha; John Barnes; Catherine Smith; Michael Shaw; Mandeep Chadha; Renu B Lal
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

View more
  9 in total

1.  Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.

Authors:  Kylie E C Ainslie; Michael Haber; Walter A Orenstein
Journal:  Vaccine       Date:  2019-03-02       Impact factor: 3.641

2.  Temporal Confounding in the Test-Negative Design.

Authors:  Natalie E Dean; M Elizabeth Halloran; Ira M Longini
Journal:  Am J Epidemiol       Date:  2020-11-02       Impact factor: 4.897

3.  Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness.

Authors:  Shuo Feng; Ashley L Fowlkes; Andrea Steffens; Lyn Finelli; Benjamin J Cowling
Journal:  Epidemiology       Date:  2017-07       Impact factor: 4.822

4.  Vaccine effectiveness and duration of protection against symptomatic infections and severe Covid-19 outcomes in adults aged 50 years and over, France, January to mid-December 2021.

Authors:  Milena Suarez Castillo; Hamid Khaoua; Noémie Courtejoie
Journal:  Glob Epidemiol       Date:  2022-05-27

5.  Cluster-Randomized Test-Negative Design Trials: A Novel and Efficient Method to Assess the Efficacy of Community-Level Dengue Interventions.

Authors:  Katherine L Anders; Zoe Cutcher; Immo Kleinschmidt; Christl A Donnelly; Neil M Ferguson; Citra Indriani; Peter A Ryan; Scott L O'Neill; Nicholas P Jewell; Cameron P Simmons
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

6.  Adjusting for calendar time in a TND influenza study.

Authors:  Jozef J P Nauta
Journal:  Epidemiol Infect       Date:  2016-05-16       Impact factor: 4.434

7.  Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children.

Authors:  Natividad Viguria; Ana Navascués; Regina Juanbeltz; Alberto Echeverría; Carmen Ezpeleta; Jesús Castilla
Journal:  Hum Vaccin Immunother       Date:  2021-01-27       Impact factor: 3.452

8.  Influenza Vaccine Effectiveness in Preventing Severe Outcomes in Patients Hospitalized with Laboratory-Confirmed Influenza during the 2017-2018 Season. A Retrospective Cohort Study in Catalonia (Spain).

Authors:  Lesly Acosta; Nuria Soldevila; Nuria Torner; Ana Martínez; Xavier Ayneto; Cristina Rius; Mireia Jané; Angela Domínguez
Journal:  Viruses       Date:  2021-07-27       Impact factor: 5.048

9.  Double Negative Control Inference in Test-Negative Design Studies of Vaccine Effectiveness.

Authors:  Kendrick Qijun Li; Xu Shi; Wang Miao; Eric Tchetgen Tchetgen
Journal:  ArXiv       Date:  2022-03-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.